Lack of complications in long-term survivors after treatment with fluosolR and oxygen as an adjuvant to radiation therapy for high-grade brain tumors

International Journal of Radiation Oncology, Biology, Physics

Volumn 26, Issue 4, 1993, Pages 649-652

  Evans, Richard G ^a   Kimler, Bruce F ^a   Morantz, Robert A ^a   Batnitzky, Solomon ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b Brain Tumor Institute   (United States)

Author keywords

FluosolR; High grade brain tumor; Late effects; Oxygen; Perfluorochemical emulsion; Radiotherapy

Indexed keywords

FLUOSOL; OXYGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN RADIATION; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MEGAVOLTAGE RADIATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION INJURY; RADIATION RESPONSE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; FEMALE; FLUOROCARBONS; HUMAN; MALE; MIDDLE AGE; OXYGEN; RADIATION-SENSITIZING AGENTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0027240060     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(93)90283-2     Document Type: Article

References (2)

1. R-DA 20% as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors
2. Univariate and multivariate statistical analysis of high-grade gliomas: The relationship of radiation dose and other prognostic factors